Distinct behavioral and neuropathological abnormalities in transgenic mouse models of HD and DRPLA

Neurobiology of Disease

Volumn 8, Issue 3, 2001, Pages 405-418

  Schilling, G ^a   Jinnah, H A ^a   Gonzales, V ^a   Coonfield, M L ^a   Kim, Y ^a   Wood, J D ^a   Price, D L ^a   Li, X J ^b   Jenkins, N ^c   Copeland, N ^c   Moran, T ^a   Ross, C A ^a   Borchelt, D R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; MUTANT PROTEIN; POLYGLUTAMINE; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BEHAVIOR DISORDER; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENE EXPRESSION; HUNTINGTON CHOREA; HYPERACTIVITY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN AGGREGATION; TRANSGENE; TRANSGENIC MOUSE; TREMOR;

EID: 0034979307     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0385     Document Type: Article

References (53)

1. The functional anatomy of disorders of the basal banglia
2. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
3. A vector for expressing foreign genes in the brains and hearts of transgenic mice
4. Behavioral pathology induced by repeated systemic injections of 3-nitroproprionic acid mimics the motoric symptoms of huntington's disease
5. Systemic 3-nitroproprionic acid: Behavioral deficits and striatla damage in adult rats
6. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
7. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene
8. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations
9. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
10. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
11. Tremors: Differential diagnosis, neurophysiology, and pharmacology
12. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
13. Trinucleotide repeat length instability and age of onset in Huntington's disease
14. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
15. Hereditary dentatorubral-pallidoluysian atrophy: Detection of widespread ubiquitinated neuronal and glial intranuclear inclusions in the brain
16. Mean genes
17. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
18. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes
19. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes
20. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human
21. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch
22. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6
23. Clinical, neuropathological, and molecular study in two families with spinocerebellar ataxia type 6 (SCA6)
24. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
25. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
26. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA)
27. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
28. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
29. Huntington's disease gene (IT15) is widely expressed in human and rat tissues
30. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
31. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
32. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
33. DRPLA gene (atrophin-1) sequence and mRNA expression in human brain
34. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA)
35. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse
36. Glutamine repeats and neurodegenerative diseases: Molecular aspects
37. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA
38. Huntington's disease and dentatorubral-pallidoluysian atrophy: Proteins, pathogenesis and pathology
39. Huntington's disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA)
40. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats
41. Formation of polyglutamine inclusions in non-CNS tissue
42. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
43. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
44. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
45. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
46. Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial?
47. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures
48. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
49. HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system
50. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice
51. Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins
52. Atrophin-1, the DRPLA gene product, interacts with ETO/MTG-8 in the nuclear matrix and represses transcription